Login / Signup

Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient.

Oliver WegehauptTina MuckenhauptMatthew B JohnsonKarl Otfried SchwabCarsten Speckmann
Published in: Journal of clinical immunology (2020)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • case report
  • glycemic control
  • cell proliferation
  • metabolic syndrome
  • skeletal muscle